Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amylyx
Amylyx
Amylyx’s ALS drug could face rejection in Europe
Amylyx’s ALS drug could face rejection in Europe
BioPharma Dive
Amylyx
ALS
EMA
Europe
Relyvrio
Flag link:
3 Biotechs That Might Get Bought Out in 2023
3 Biotechs That Might Get Bought Out in 2023
Motley Fool
M&A
Madrigal Pharmaceuticals
Amylyx
Aurinia Pharmaceuticals
Flag link:
Amylyx’s ALS drug sales impress Wall Street
Amylyx’s ALS drug sales impress Wall Street
BioPharma Dive
Amylyx
ALS
Relyvrio
Flag link:
Amylyx completes subject enrollment in ALS therapy trial
Amylyx completes subject enrollment in ALS therapy trial
Clinical Trials Arena
Amylyx
clinical trials
AMX0035
ALS
Flag link:
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
BioPharma Dive
Amylyx
Relyvrio
ALS
patients
physicians
Flag link:
FDA seems poised to approve a new drug for ALS, but does it work?
FDA seems poised to approve a new drug for ALS, but does it work?
NPR
Amylyx
AX0035
FDA
ALS
Flag link:
Highlighted by Amylyx, the ALS Space is Gaining Momentum
Highlighted by Amylyx, the ALS Space is Gaining Momentum
BioSpace
ALS
AMX0035
Amylyx
GeNeuro
NeuroSense Therapeutics
BrainStorm Cell Therapeutics
Flag link:
FDA advisers back Amylyx ALS drug, reversing earlier position
FDA advisers back Amylyx ALS drug, reversing earlier position
BioPharma Dive
Amylyx
FDA
ALS
AMX0035
Flag link:
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
FDA
drug approvals
Amicus
Bluebird Bio
Bristol Myers Squibb
Eli Lilly
Marinus Pharma
Amylyx
Novartis
Flag link:
FDA to reconvene experts' meeting for Amylyx ALS drug
FDA to reconvene experts' meeting for Amylyx ALS drug
Yahoo/Reuters
Amylyx
ALS
FDA
AMX0035
Flag link:
Go or no go? The FDA’s Amylyx dilemma
Go or no go? The FDA’s Amylyx dilemma
EP Vantage
FDA
Amylyx
AMX0035
ALS
COVID-19
vaccines
Novavax
Moderna Therapeutics
Pfizer
Acadia Pharma
Bluebird Bio
Flag link:
An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway
An FDA panel reviewing Amylyx's ALS drug was moved by patient testimony—but they voted it down anyway
Fierce Biotech
Amylyx
ALS
FDA
patients
AMX0035
Flag link:
Amylyx faces an uphill battle
Amylyx faces an uphill battle
EP Vantage
Amylyx
FDA
AMX0035
Flag link:
Amylyx to answer for single-study ALS application at FDA advisory panel
Amylyx to answer for single-study ALS application at FDA advisory panel
Fierce Biotech
Amylyx
ALS
clinical trials
FDA
Flag link:
As three biotechs head to Wall Street, a battered sector braces for a pullback
As three biotechs head to Wall Street, a battered sector braces for a pullback
BioPharma Dive
Amylyx
CinCor
Vigil Neuroscience
IPOs
biotech
Flag link:
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Endpoints
Amylyx
ALS
funding
NASDAQ
Flag link:
Amylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
Amylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
MedCity News
Amylyx
ALS
clinical trials
FDA
Flag link:
After a rare win, a biotech details long-awaited results for its ALS drug
After a rare win, a biotech details long-awaited results for its ALS drug
BioPharma Dive
ALS
AMX0035
Amylyx
FDA
Flag link:
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D
Endpoints
R&D
startups
ALS
Lou Gehrig's disease
Amylyx
Henri Termeer
Flag link: